J&J, Amgen Scrutinized For Anemia Drug Marketing
By Shannon Henson ( April 2, 2008, 12:00 AM EDT) -- Congressional leaders have asked Johnson & Johnson and Amgen Inc. to turn over records related to the advertising and marketing of their anemia drugs amid reports of increased risks of blood clots and death when used in high doses....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.